• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克林霉素/伯氨喹治疗及对艾滋病患者卡氏肺孢子虫肺炎的二级预防

Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.

作者信息

Kay R, DuBois R E

机构信息

Division of Infectious Diseases, Georgia Baptist Medical Center, Atlanta.

出版信息

South Med J. 1990 Apr;83(4):403-4. doi: 10.1097/00007611-199004000-00010.

DOI:10.1097/00007611-199004000-00010
PMID:2321069
Abstract

We found a program of intravenous and subsequent oral clindamycin, combined with oral primaquine, to be effective for Pneumocystis carinii pneumonia in nine patients with AIDS. The pneumonias were either primary or recurrent and sometimes severe, with cavity formation and/or pneumothorax. Maintenance therapy at lowered dose by mouth was effective in preventing recurrence in seven patients. One patient died of other opportunistic infections on day 24, and therapy was discontinued in another on day 11 because of skin rash. We conclude that clindamycin/primaquine is effective for therapy of P carinii pneumonia in patients with AIDS, as well as for long-term secondary prophylaxis at lowered dosage.

摘要

我们发现,对于9例艾滋病患者的卡氏肺孢子虫肺炎,静脉注射随后口服克林霉素并联合口服伯氨喹的方案有效。这些肺炎要么是原发性的,要么是复发性的,有时很严重,伴有空洞形成和/或气胸。7例患者通过低剂量口服维持治疗有效预防了复发。1例患者在第24天死于其他机会性感染,另1例患者在第11天因皮疹而停止治疗。我们得出结论,克林霉素/伯氨喹对艾滋病患者的卡氏肺孢子虫肺炎治疗有效,对低剂量长期二级预防也有效。

相似文献

1
Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.克林霉素/伯氨喹治疗及对艾滋病患者卡氏肺孢子虫肺炎的二级预防
South Med J. 1990 Apr;83(4):403-4. doi: 10.1097/00007611-199004000-00010.
2
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.艾滋病患者卡氏肺孢子虫肺炎轻至中度发作的克林霉素和伯氨喹治疗:艾滋病临床试验组044研究
Clin Infect Dis. 1994 Jun;18(6):905-13. doi: 10.1093/clinids/18.6.905.
3
Clindamycin with primaquine for Pneumocystis carinii pneumonia.克林霉素联合伯氨喹治疗卡氏肺孢子虫肺炎。
Lancet. 1989 May 13;1(8646):1046-8. doi: 10.1016/s0140-6736(89)92446-x.
4
Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS.克林霉素和伯氨喹作为艾滋病患者轻度至中度严重卡氏肺孢子虫肺炎的一线治疗药物。
Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):204-7. doi: 10.1007/BF01964465.
5
Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia.克林霉素/伯氨喹与甲氧苄啶/磺胺甲恶唑在卡氏肺孢子虫肺炎初始治疗中的疗效比较
Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):207-10. doi: 10.1007/BF01964466.
6
Clindamycin/primaquine for treatment of Pneumocystis carinii pneumonia in AIDS.克林霉素/伯氨喹用于治疗艾滋病患者的卡氏肺孢子虫肺炎。
Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):210-3. doi: 10.1007/BF01964467.
7
Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia.克林霉素/伯氨喹用于卡氏肺孢子虫肺炎的挽救治疗。
Clin Infect Dis. 1992 Jan;14(1):183-8. doi: 10.1093/clinids/14.1.183.
8
Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia.卡氏肺孢子虫肺炎预防中的困境
South Med J. 1994 Apr;87(4):429-30. doi: 10.1097/00007611-199404000-00001.
9
Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.艾滋病患者轻度至中度卡氏肺孢子虫肺炎三种治疗方案的比较。口服甲氧苄啶-磺胺甲恶唑、氨苯砜-甲氧苄啶和克林霉素-伯氨喹的双盲、随机试验。美国国立过敏与传染病研究所艾滋病临床试验组108研究小组。
Ann Intern Med. 1996 May 1;124(9):792-802. doi: 10.7326/0003-4819-124-9-199605010-00003.
10
[Clindamycin and primaquine in the treatment of pulmonary pneumocystosis in a HIV-positive female patient].[克林霉素和伯氨喹治疗一名HIV阳性女性患者的肺孢子菌肺炎]
Ann Med Interne (Paris). 1993;144(1):61-3.

引用本文的文献

1
Clinical Pharmacology in Sarcoidosis: How to Use and Monitor Sarcoidosis Medications.结节病的临床药理学:如何使用和监测结节病药物
J Clin Med. 2024 Feb 22;13(5):1250. doi: 10.3390/jcm13051250.
2
Pneumonia in Children with Hematological Malignancies: Diagnosis and Approaches to Management.血液系统恶性肿瘤患儿的肺炎:诊断与管理方法
J Fungi (Basel). 2020 Dec 2;6(4):331. doi: 10.3390/jof6040331.
3
Opportunistic infections in HIV-infected patients.HIV感染患者的机会性感染。
Can J Infect Dis. 1992 Mar;3(2):82-7. doi: 10.1155/1992/413713.
4
Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate.8-氨基喹啉8-[(4-氨基-1-甲基丁基)氨基]-6-甲氧基-4-甲基-5-[3,4-二氯苯氧基]喹啉琥珀酸盐各对映体的抗寄生虫活性和毒性
Antimicrob Agents Chemother. 2008 Jun;52(6):2130-7. doi: 10.1128/AAC.00645-07. Epub 2008 Mar 31.
5
Treatment of infection due to Pneumocystis carinii.卡氏肺孢子菌感染的治疗。
Antimicrob Agents Chemother. 1998 Jun;42(6):1309-14. doi: 10.1128/AAC.42.6.1309.
6
Prevention of infection due to Pneumocystis carinii.预防卡氏肺孢子虫感染。
Antimicrob Agents Chemother. 1998 May;42(5):995-1004. doi: 10.1128/AAC.42.5.995.
7
Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.卡氏肺孢子虫肺炎治疗中的药代动力学优化
Clin Pharmacokinet. 1993 May;24(5):388-412. doi: 10.2165/00003088-199324050-00004.
8
Pneumocystis carinii, an opportunist in immunocompromised patients.卡氏肺孢子菌,一种免疫功能低下患者体内的机会致病菌。
Clin Microbiol Rev. 1991 Apr;4(2):137-49. doi: 10.1128/CMR.4.2.137.
9
8-Aminoquinolines from Walter Reed Army Institute for Research for treatment and prophylaxis of Pneumocystis pneumonia in rat models.来自沃尔特·里德陆军研究所的8-氨基喹啉用于大鼠模型中卡氏肺孢子虫肺炎的治疗和预防。
Antimicrob Agents Chemother. 1991 Feb;35(2):277-82. doi: 10.1128/AAC.35.2.277.
10
Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs.卡氏肺孢子虫二氢叶酸还原酶用于筛选潜在的抗肺孢子虫药物。
Antimicrob Agents Chemother. 1991 Jul;35(7):1348-55. doi: 10.1128/AAC.35.7.1348.